Characterization of [3H]morphine binding to interleukin-1-activated thymocytes

Area of Science:

• Immunology
• Neuroscience
• Pharmacology

Background:

• Interleukin-1 (IL-1) stimulates thymocyte proliferation.
• Previously observed [3H]morphine binding sites on thymocytes during IL-1-induced proliferation.

Purpose of the Study:

• Characterize the nature of [3H]morphine binding sites on thymocytes.
• Compare these sites to classical opioid receptors.
• Investigate the potential role of these sites in T-cell regulation.

Main Methods:

• Characterization of [3H]morphine binding sites on thymocyte membranes.
• Assessing binding affinity, capacity, stereoselectivity, and ion dependency.
• Enzymatic treatment of membranes (proteinase K/E, phospholipase A2, trypsin).
• Flow cytometry to identify cell subsets (CD4+ T-cells).

Main Results:

• Binding sites exhibit lack of stereoselectivity and relatively low affinity (Kd = 50 nM) with high capacity (Bmax = 3 pmol/mg protein).
• Binding is inhibited by specific ions (Ca++, Mg++, Mn++, Cl-) and enzymatic treatments (proteinase K/E, phospholipase A2).
• Sites are predominantly found on CD4+ T-cells and prefer opioid alkaloids over peptides.
• These sites differ significantly from classical brain opioid receptors.

Conclusions:

• The identified [3H]morphine binding sites on thymocytes are distinct from central nervous system opioid receptors.
• These novel binding sites may play a role in modulating IL-1-induced thymocyte proliferation.
• Potential negative feedback mechanism on T-cell proliferation mediated by these sites in vivo.